OSE Immunotherapeutics SA
PAR:OSE

Watchlist Manager
OSE Immunotherapeutics SA Logo
OSE Immunotherapeutics SA
PAR:OSE
Watchlist
Price: 5.8 EUR 1.4%
Market Cap: 127.3m EUR

OSE Immunotherapeutics SA
Other

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

OSE Immunotherapeutics SA
Other Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other CAGR 3Y CAGR 5Y CAGR 10Y
OSE Immunotherapeutics SA
PAR:OSE
Other
-€469k
CAGR 3-Years
N/A
CAGR 5-Years
-24%
CAGR 10-Years
N/A
Valneva SE
PAR:VLA
Other
-€20m
CAGR 3-Years
-33%
CAGR 5-Years
-50%
CAGR 10-Years
N/A
G
Genfit SA
PAR:GNFT
Other
-€348k
CAGR 3-Years
43%
CAGR 5-Years
46%
CAGR 10-Years
-13%
Inventiva SA
PAR:IVA
Other
€68.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
DBV Technologies SA
PAR:DBV
Other
-$222k
CAGR 3-Years
45%
CAGR 5-Years
40%
CAGR 10-Years
N/A
Eurobio Scientific SA
PAR:ALERS
Other
-€2.3m
CAGR 3-Years
-6%
CAGR 5-Years
0%
CAGR 10-Years
N/A

OSE Immunotherapeutics SA
Glance View

Market Cap
126.6m EUR
Industry
Biotechnology

OSE Immunotherapeutics SA develops immunotherapy products for cancer and auto-immune disease. The company is headquartered in Nantes, Pays De La Loire and currently employs 61 full-time employees. The company went IPO on 2015-03-30. The company develops immunotherapies, directly or through partnerships, for the activation and regulation of the immune system in immuno-oncology and in autoimmune diseases. The firm's research and development in immunology is based on 3 platforms, such as T cell-based vaccines, Immuno-Oncology (myeloid targets) and Auto-Immunity & Inflammation. The company provides technological and scientific platforms: neoepitopes, agonist or antagonist monoclonal antibodies, ideally positioned to fight cancer and autoimmune diseases.

OSE Intrinsic Value
3.74 EUR
Overvaluation 36%
Intrinsic Value
Price

See Also

What is OSE Immunotherapeutics SA's Other?
Other
-469k EUR

Based on the financial report for Dec 31, 2024, OSE Immunotherapeutics SA's Other amounts to -469k EUR.

What is OSE Immunotherapeutics SA's Other growth rate?
Other CAGR 5Y
-24%

Back to Top